IPO Premiums
IPO calendar
RPListed

Remus Pharmaceuticals Limited

Bookbuilding IPO · NSE

Price band
₹1150 - ₹1229
Lot size
100 shares
Issue amount
₹47.69 cr
Total subscription
61.53×
Current price₹984.5
Listing price ₹1,711.25
Watch live price ↗
Opens
17 May 2023
Closes
19 May 2023
Allotment
24 May 2023
Listing
29 May 2023

Offer at a glance

Issue overview

Issue size
3,88,000 shares
Face value
₹10 per share
Minimum investment
₹1,15,000
Fresh issue
₹47.69 cr
Offer for sale
₹0 cr
Registrar
Link Intime India Private Limited
Listing exchange
NSE
Maximum investment
₹1,22,900
Issue type
Bookbuilding IPO
Shares before issue
10,85,000
Shares after issue
14,73,000

Lot sizes

CategoryLotsSharesAmount
RETAIL1100₹1,22,900
HNI2200₹2,45,800

Share reservation

Retail33.25%
NII(HNI)14.25%
QIB47.47%
Market Maker5.03%

Subscription & GMP

Subscription by category

Total subscribed61.53×

Missing multiples are calculated from bids and offered shares when available.

QIB20.24×
NIB172.6×
RETAIL37.5×

GMP history

023547021 Mar: ₹47011 Nov: ₹470
21 Mar₹47011 Nov

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs9.06183.37
RETAIL15.85594.54
NIB6.81,173.08

Financial performance

Company financials

In Lakhs · Reported periods may include interim results.

Revenue & profitIn Lakhs
01,0002,0003,0004,000Dec 2022 · Revenue: 3,361.2Dec 2022 · Profit after tax: 643.9Dec 2022Mar 2022 · Revenue: 2,543.71Mar 2022 · Profit after tax: 338.57Mar 2022Mar 2021 · Revenue: 1,922.45Mar 2021 · Profit after tax: 102.58Mar 2021Mar 2020 · Revenue: 1,276.89Mar 2020 · Profit after tax: 81.16Mar 2020
RevenueProfit after tax

Key performance indicators

MetricValues
EPS33.86
ROE71.44
ROCE69.99
RONW52.64
PRE IPO(PE)21.09
POST IPO(PE)0

Values and labels as reported in the issue data.

Company information

Company profile

Incorporated in 2015, Remus Pharmaceuticals Limited is engaged in the marketing and distribution of pharmaceutical products, including Active Pharmaceutical Ingredients (APIs) and finished formulations in various dosage forms. As of January 31, 2023, the company offers 429 products, with 295 registered in 13 countries and 134 under registration in 16 countries. Remus Pharmaceuticals maintains business-to-business agreements with 58 domestic and 139 international distributors, serving clients across more than 20 countries, including generic distributors, regional distributors, multinational distributors, hospitals, and clinics.

Promoters

Mr. Arpit Deepakkumar Shah

Ms. Roma Vinodbhai Shah

Mr. Swapnil Jatinbhai Shah

Mrs. Anar Swapnil Shah

Registrar & documents

Lead manager

Beeline Capital Advisors Private Limited

Registered office

1101 to 1103, South Tower, One 42, B/H Ashok Vatika, Nr. Jayantilal Park BRTS, Ambli bopal Road, Ahmedabad - 380054

+079- 2999 9857

[email protected]Company website ↗

Frequently Asked Questions

What is Remus Pharmaceuticals IPO GMP today?

As of today, Remus Pharmaceuticals IPO Grey Market Premium (GMP) is reported at +₹470 per share. Based on the upper price band of ₹1,229, the estimated listing price is ₹1,699 (+38.2% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.

What is the lot size and minimum investment for Remus Pharmaceuticals IPO?

The minimum bid lot size for Remus Pharmaceuticals IPO is 100 shares. At the cut-off price of ₹1,229 per share, retail investors need a minimum application amount of ₹1,22,900 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).

When will Remus Pharmaceuticals IPO allotment status be announced?

The allotment status for Remus Pharmaceuticals IPO is scheduled to be finalized on 24 May 2023. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Link Intime India Private Limited's official portal or via BSE/NSE allotment portals.

How can I check Remus Pharmaceuticals IPO allotment status online by PAN?

To check Remus Pharmaceuticals IPO allotment status: 1) Visit the registrar portal (Link Intime India Private Limited) or the BSE IPO allotment page. 2) Select 'Remus Pharmaceuticals Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.
Remus Pharmaceuticals IPO GMP Today, Subscription Status & Allotment Date | IPO Premiums